Chinese audiologists' attitudes toward MSTB adoption are informative for protocol harmonization efforts, but this retrospective survey does not itself provide evidence sufficient to change existing cochlear implant testing practices.
Standardizing speech testing for cochlear implant users across international clinical settings is essential for comparing outcomes and guiding rehabilitation, and understanding barriers to MSTB adoption in China could accelerate that harmonization.
- 01Reviews the revised Minimum Speech Test Battery (MSTB) for adult cochlear implant users.
- 02Surveys Chinese audiologists on awareness of and responses to the updated MSTB.